Me lōʻihi Metformin

Kuhi ʻia ka Metformin lōʻihi i nā maʻi me ka hōʻemi ʻana i nā pae glucose glucose. Hoʻohui maikaʻi, ua kauoha ʻia nā mea hana no ka poʻe makemake e hōʻemi i ka paona.

ʻO ka lāʻau o ka pūʻulu biguanide e hōʻino i nā hopena kūponoʻole o ke kino, no laila he mea nui ke kiʻi i ke kūkā o ke kauka ma mua o ka hoʻomaka ʻana o ka mālama ʻana.

Inoa Kūʻai ʻole honua

Metformin (inoa Latin) - ka inoa o ka mea ikaika.

Kuhi ʻia ka Metformin lōʻihi i nā maʻi me ka hōʻemi ʻana i nā pae glucose glucose.

A10BA02 - pāʻālua no ka hoʻonaninani a me ka therapeutic chemical classification.

E hoʻokuʻu i nā palapala a me ka ʻano

Loaʻa nā papa ʻaina (lōʻihi hana) i loko o nā pūkela polymer o 30 pcs. ma kela paena keia, a me 5 a 10 paha pcs. i loko o ka ʻaki hoʻokoe.

Aia kēlā me kēia papa i 850 mg a i ʻole 1000 mg o ka pakanui mau.

Aia kēlā me kēia papa i 850 mg a i ʻole 1000 mg o ka pakanui mau.

Ka hana lāʻau lapaʻau

Loaʻa ka Metformin i ka hopena hypoglycemic, e hoʻemi ana i ka mea huna o ka glucose i nā huapalapala a pohi a hoʻōla i kona komo ʻana i ka ʻawaʻawa.

I ka wā o ka hoʻohana ʻana i ka Metformin, ua nānā ʻia kahi emi o ke kaumaha kino maʻi ma muli, no ka mea ka hana ikaika o ka lāʻau i ka hopena maikaʻi i ka hana o ka pūnao mea hoʻohui, e komo ai, nā momona (lipids).

Lapaʻau lāʻau

Hoʻomaʻa ʻia ka Metformin mai ka līkika i ka ʻōnaehana ʻōnaehana. Inā ʻoe e lawe i nā paila me ka meaʻai, a laila he lōʻihi ke kaʻina o ka lawe ʻana o ka mea hana.

Hoʻopiliʻia nā huahana decomposition o ka waiwai ikaika e nā keiki me ka urine a he hapa liʻiliʻi o nā metabolites i loaʻa i nā feces.

Inā ʻoe e lawe i nā paila me ka meaʻai, a laila he lōʻihi ke kaʻina o ka lawe ʻana o ka mea hana.

Nā hōʻailona no ka hoʻohana ʻana

Ua kuhikuhi ʻia kahi kahu hypoglycemic no:

• momo a me ke ʻano maʻi type 2
• obesity, inā pono ke kaohi i ka neʻe o ka glucose i ke koko, ʻaʻole hiki ke loaʻa e ka nānā ʻana i nā loina o ka meaʻai a me ka hoʻomaʻamaʻa,
• polycystic ovary, akā ma lalo o ka nānā o kahi kauka.

Ua kuhikuhi ʻia kahi kuhikuhi hypoglycemic no ka maʻi type a me ka type 2.Hoʻomaopopo ʻia kahi huakaʻi hypoglycemic no ka luhi, inā pono ka kontrol i ka ʻike ʻana o ka glucose i ke koko.Hoʻomaopopo ʻia kahi lawena hypoglycemic no ka polycystic ovary, akā ma lalo o ka nānā o kahi kauka.

Nā Hoʻohui

Hoʻohui ʻia ka mea hana me ka:

• intolerance pilikino e metformin,
• hana hōʻeha a me ka hana renaline (hana i hana ʻia ma kahi o 45-59 ml / min.),
• e hoomau ana
• ʻōpala palupalu,
• myocardial pili hewa
• ka haʻalele ʻana o ke kaulike wai-electrolyte,
• ʻaʻano kai hypocaloric
• hoʻonui i nā pae o ka lactic acid i ke koko (lactic acidosis),
• ka ʻalo kala kala ʻana.

Hoʻopilikia ka lāʻau lapaʻau no ka hoʻohana ʻana i ka hihia o ka hana renal impaired (cleinine clearance 45-59 ml / min.).

Pehea e lawe ai iā Metformin Long

He mea nui ia e hahai i nā ʻōlelo aʻo no ka hoʻohana ʻana i ka lāʻau lapaʻau e hoʻokō i ka dinamics kūpono o nā hōʻailona lapaʻau.

Aia kekahi o ia mau hiʻohiʻona:

1. ʻAʻole hoʻi e ʻawa ʻia ka papa papa. Inā paʻakikī no kahi maʻi e hoʻolele i kahi papa o 0.85 g, pono ʻia e hoʻokaʻawale iā ia i 2 mau māhele, ka mea i lawe ʻia ma hope o kekahi, ʻaʻole e nānā i ka wā manawa.
2. Pono pono e inu i ka lāʻau lapaʻau me ka nui o ka wai e pale ai i nā pilikia me ka pīpī.
3. Hoʻonui ka hewa o ka waihona waiwai ma hope o nā lā 10-14.
4. ʻO ka nui loa o ka helu o kēlā me kēia lā o Metformin he 3000 mg.

ʻAʻole hoʻi e ʻawa ʻia ka papa papa. Inā paʻakikī kahi mea maʻi e hoʻoō i kahi papa o ka 0.85 g, pono ia e hoʻokaʻawale iā ia i 2 mau māhele.

No ka hoʻoluhi kaumaha

Ke koho ʻia nei ka helu Dose. I ka hapa nui, ʻo ka hapa nui o kēlā me kēia lā o Metformin ʻaʻole iʻoi aku ma mua o 2000 mg.

No ka hoʻolilo ʻana, lawe ʻia ke koho ʻana i kēlā me kēia.

Hoʻohana i ka wā hāpai a me ka lactation

Hoʻohana ʻia ka hoʻohana ʻana i nā papa i nā wahine hāpai a i ka wā o ka ʻōpū, e like me ʻO ka hanaʻino ʻole o kēia kānāwai e hōʻino ai i ke keiki.

Hoʻohana ʻia ka hoʻohana ʻana i nā papa i nā wahine hāpai a i ka wā o ka ʻōpū, e like me ʻO ka hanaʻino ʻole o kēia kānāwai e hōʻino ai i ke keiki.

Hoʻopili pū me nā lāʻau ʻē aʻe

He mea nui e noʻonoʻo i nā mea aʻe:

1. Hiki i ka hypoglycemia me ka hoʻohana pinepine ʻana o nā derivatives o ka sulfonylurea.
2. Ke hui pū me ka cimetidine, e iho ana ke kaʻina o Metformin mai ke kino.
3. ʻO ka hoʻohālikelike o ka lāʻau me nā lāʻau lapaʻau e pili ana i ka iodine, ua contraindicated. Lilo ʻia ia mau lāʻau no nā haʻawina x-ray. Aia kahi kūlana kiʻekiʻe nui o ka hoʻomohala ʻana i ka maʻi haki i kēia hihia.
4. Hoʻokomo ka Nifedipine i ka hopena hypoglycemic o Metformin.

Hoʻokomo ka Nifedipine i ka hopena hypoglycemic o Metformin.

Hōʻikeʻike e pili ana iā Metformin Long

Aia nā hopena kūpono a me nā hopena maikaʻi e pili ana i nā mea hōʻola o ka lāʻau.

ʻO Anatoly Petrovich, 34 makahiki, Moscow

Ke kau nei wau i kēia lāʻau lapaʻau i nā mea maʻi pākeke no ka loaʻa o ka maʻi maʻi. Ma ka hoʻomaʻamaʻa lapaʻau, ʻaʻole au i loaʻa i nā hopena hopena i ka lawe ʻana i nā papa retard. Mālama ʻia ka pae ʻana o ka pae koko koko no ka 14 mau lā.

Yuri Alekseevich, 38 makahiki, St.

Kumuhana i nā lula no ka lawe ʻana i ka lāʻau lapaʻau, ʻaʻohe ʻano like ʻole o ke kino. Ma nā kīʻaha pilikia a ka wahine i ka malaise a me ka pau ʻole o ka makemake. ʻAʻole wau e'ōlelo i ka lāʻau lapaʻau no nā poʻe maʻi me ka hana pūlima hemahema.

-Metformin ʻike maoliMETFORMIN no ka maʻi maʻi a me ka momona.

Olga, 50 ona makahiki, Omsk

Ua mālama ʻia me Metformin no ka manawa lōʻihi, ʻo ia ke kumu no ka hoʻopio ʻole ʻana o ka huaora B12. Ma muli o kēia halaʻole, kūkuluʻia ka anemia megaloblastic. Pono ka lāʻau lapaʻau e mālama me ka akahele a he mea nui ia e hoʻomaʻamaʻa i ka hoʻokolokolo diagnostic i kahi manawa kūpono.

Mikhail, 45 makahiki, Perm

Ua hauʻoliʻo ia i ka hopena o ka mālama ʻana me Metformin. ʻO ka lawe ʻana i nā paila, ʻaʻole ia i palena i ka koho o ka hana ʻoihana. ʻAʻole pili ka lāʻau lapaʻau i ka hoʻokele o nā mīkini paʻakikī, no laila hiki ke hoʻohana iā ia i ka wā e pili ana ka hana me ka hoʻonui nui o ka manaʻo.

Larisa, 34 makahiki, Ufa

ʻAʻole i loaʻa ka hopena i makemake ʻia. Ua hahai wau i kahi papaʻai a ʻaʻole iʻoi aku i ka loaʻa ʻana o ka nui o nā mea ikaika i hoʻokumu ʻia e ke kauka. E hoʻohālikelike i ka puʻu mau a me ka hoʻonāukiuki kūpilikiʻi ma ka lā 5 o ka lawe ʻana i ka hopena.

Julia, 40 makahiki, Izhevsk

ʻAʻole i loaʻa kahi hopena ʻino, akā hiki ʻole ke loaʻa nā paona ma hope o ka malama o ka lawelawe ʻana o nā papa hoʻonohonoho i nā papa.

ʻŌpū a me ka lactation

ʻO ka lawa ʻana a ʻike paʻa ʻia nā haʻawina e pili ana i ka palekana o ka metformin i ka wā hāpai ʻana ʻaʻole i mālama ʻia. Hiki ke hoʻohana ʻia i ka wā hāpai a hiki i nā pilikia hōʻeha, ke loaʻa ka hopena i manaʻo ʻia no ka mālama ʻana i ka maʻi no ka makuahine. Hoʻopau ka Metformin i ka pale papalua.

ʻO Metformin i loko o kahi liʻiliʻi ka mea i hoʻopihapiha ʻia i loko o ka waiū umauma, aʻo ka hoʻokūkū o ka metformin i loko o ka waiū umauma hiki ke 1/3 o ke kūpaʻa ʻana i ka plasma o ka makuahine. Hoʻokomo ʻia nā hopena i nā keiki hou i ka wā o ka wā o ka ʻōpū o ka wā e lawe ai i ka metformin i ʻike ʻole ʻia. Eia naʻe, ma muli o ka nui o ka waiwai o ka ʻikepili, ʻaʻole i ʻōlelo ʻia ka hoʻohana i ka wā o ka hoʻoulu ʻana. ʻO ka hoʻoholo e pani i ka hōʻuluʻulu ʻana e pono e mālama i nā pono o ka umauma a me ka hiki o nā hopena kūpono i nā hopena kūpono i ka pēpē.

Ua hōʻike ʻia nā haʻawina preclinical i ka metformin ʻaʻole i loaʻa nā hopena teratogenic i nā pona i ko 2-3 mau manawa iʻoi aku ma mua o nā papa lāʻau therapeutic i hoʻohana ʻia e nā kānaka. ʻAʻohe o Metformin i kahi puʻuwai mutagenic, ʻaʻole pili i ka huaʻai.

Nā nīnau, pane, ʻōlelo pili i ka lāʻau Metformin Long

ʻO ka ʻikepili i hāʻawi ʻia e hana no nā lāʻau lapaʻau a me nā lāʻau lapaʻau. Aia nā ʻike e pili ana i ka lāʻau lapaʻau e pili ana i nā ʻōlelo i hoʻopili ʻia e ka mea hoʻopiʻi e ka mea hana. ʻAʻohe ʻikepili i hoʻopili ʻia ma kēia a ʻole kekahi ʻaoʻao o ka pūnaewele a mākou e hiki ke lawelawe ma kahi kūʻokoʻa no ka hoʻopiʻi pilikino i ka loea.